Understanding how migraines become chronic and how to reverse that process
Mechanisms of migraine chronification and reversal
This study is looking at how certain immune cells might help improve chronic migraines, using a mouse model to see if a treatment called low-dose interleukin-2 can help balance the immune system and reduce migraine symptoms for people who suffer from them.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11071989 on NIH RePORTER |
What this research studies
This research investigates the role of specific immune cells, particularly CD3+ T lymphocytes and regulatory T cells, in the development and potential reversal of chronic migraines. By using a mouse model that mimics chronic migraine conditions, the study examines how these immune cells behave and how treatments like low-dose interleukin-2 can restore balance in the immune system. The goal is to uncover new therapeutic strategies that could alleviate the debilitating effects of chronic migraines for patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from chronic migraines who may have immune system imbalances.
Not a fit: Patients with acute migraines or those who do not have any immune system involvement in their migraine condition may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that effectively reverse chronic migraines and improve patients' quality of life.
How similar studies have performed: Previous research has shown promise in using immune modulation to treat chronic conditions, suggesting that this approach may yield beneficial results.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Cao, Yuqing — Washington University
- Study coordinator: Cao, Yuqing
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.